Fresenius Medical Care AG / DE0005785802

Fresenius Medical Care AG: Share buyback Disclosure pursuant to Art. 5 para. 1 lit. b) of Regulation (EU) No. 596/2014 Share buyback – Interim Report In the period from September 1, 2025 to September 5, 2025 (each inclusive), 763,069 shares were bought back within the framework of the share buyback of Fresenius Medical Care AG, the start of which was disclosed on August 11, 2025 pursuant to Art. 5 para. 1 lit. a) of Regulation (EU) No. 596/2014, Art. 2 para. 1 of Delegated Regulation (EU) 2016/1052. Shares were bought back as follows:

Date	Acquired shares (number)	Weighted average price (in EUR)	Transaction volume (in EUR)	Trading venue
2 September 2025	18,726	41.8738	784,128.22	AQEU
2 September 2025	88,296	41.8728	3,697,197.77	CEUX
2 September 2025	10,776	41.8626	451,111.60	TQEX
2 September 2025	139,271	41.8651	5,830,592.96	XETA
3 September 2025	9,582	41.8302	400,816.73	AQEU
3 September 2025	76,907	41.9723	3,227,964.62	CEUX
3 September 2025	139,511	41.9775	5,856,320.94	XETA
4 September 2025	5,500	41.6732	229,202.75	AQEU
4 September 2025	23,548	41.6373	980,476.02	CEUX
4 September 2025	125,952	41.7024	5,252,498.03	XETA
5 September 2025	125,000	41.8554	5,231,920.77	XETA

A total of 2,847,802 shares have been acquired within the framework of this share buyback. The purchase of the shares is carried out by a credit institution commissioned by Fresenius Medical Care AG. Fresenius Medical Care AG will provide regular information regarding the progress of the share buyback, including by posting its required disclosures at https://freseniusmedicalcare.com/en/investors/shares/share-buyback/.